The world’s newest petrostate heads to the polls

Summary

---

FT News Briefing – "The world’s newest petrostate heads to the polls"

Date: September 1, 2025
Host: Persis Love (B)
Guests: Joe Daniels (D, Andean Correspondent), Eleanor Olcott (C, China Correspondent)

---

Main Theme

This episode of the FT News Briefing covers three major global business stories:

• The evolving diplomatic and economic relationship between China and India
• Guyana’s pivotal election as the world’s newest petrostate
• How AstraZeneca has rebounded in China after a recent scandal

---

Key Discussion Points & Insights

1. China-India Relations Tighten

• Summary: Chinese President Xi Jinping and Indian Prime Minister Narendra Modi met at a regional security summit in Xi’anxin, China, signaling improved ties between the two nuclear powers despite recent tensions.
• Details:
  • Both leaders emphasized partnership over rivalry amid ongoing US trade wars.
  • India faces a world-leading 50% tariff on exports to the US, fostering pragmatic cooperation between the Asian giants.
• Memorable Quote:
  • “China and India are, quote, partners, not rivals. So said Chinese President Xi Jinping after meeting with his Indian counterpart, Narendra Modi.” – Persis Love [00:45]

Timestamps:

• [00:45] "China and India are, quote, partners, not rivals..."
• [01:20] Context of nuclear stockpiles and Himalayan border tensions

---

2. Guyana: Election in a New Petrostate

The Oil Boom’s Impact

• Summary: Guyana, now the fastest-growing economy after ExxonMobil’s oil discoveries, is undergoing a transformational election that could shape the nation’s future.
• Country Context (Joe Daniels):
  • Guyana's population: 830,000
  • Oil discoveries: 11 billion barrels of oil equivalent
  • Oil per capita: "Equivalent to the Middle East"
  • Recent transformation: From 2nd poorest in Western Hemisphere to fastest-growing economy
  • Potential $41bn revenue windfall over the next five years

Election Dynamics

• Key Political Players:

  • Incumbent: President Irfan Ali (People’s Progressive Party)
    • Pro-Exxon, focuses on large infrastructure, public-private partnerships.
  • Opposition: Aubrey Norton (Partnership for National Unity, APNU)
    • Promises direct benefits to citizens, appeals to those yet to feel the oil boom’s effects.
  • Potential Spoiler: Azreddin Mohammed’s WIN Party
    • Populist, pledges to renegotiate Exxon terms, seeks national unity, may disrupt the two-party system.

• Significance:

  • The election is critical given the influx of oil wealth.
  • Risks include the ‘resource curse’ (corruption, economic distortion, vulnerability to oil price shocks).
  • Quote: "It's so momentous because the sheer size of revenues... are so enormous over the next presidential term." – Joe Daniels [05:14]

Timestamps:

• [02:08] Joe Daniels explains oil’s impact on Guyana
• [03:03] Candidates’ contrasting visions
• [04:13] Azreddin Mohammed’s WIN Party described as a potential spoiler
• [05:14] “Mother of all elections” and exploration of resource curse risks

---

3. UK Wins Major Warship Contract with Norway

• Summary: The UK secures a £10 billion contract to supply Norway with at least five warships, marking the sector’s largest-ever deal.
• Details:
  • Ships (frigates) will be built by BAE Systems in Glasgow.
  • Aimed at countering increased Russian submarine activity in the Arctic and North Atlantic.
  • British, Norwegian, and US forces have recently monitored a Russian submarine in the region.
  • BAE Systems also supports shipbuilding for Canada and Australia.

Timestamps:

• [06:13] Details on the UK-Norway deal and strategic significance

---

4. AstraZeneca’s Recovery in China

Scandal Background

• Summary: After a major scandal and the arrest of its China boss (Leon Wang) over alleged illegal drug sales, AstraZeneca’s China operations are recovering.
• Backstory:
  • AstraZeneca: largest foreign pharmaceutical company by sales in China.
  • The scandal led to a 10% drop in share price.

Signs of Recovery

• Performance:

  • Sales in China up 4% in first half of the year.
  • Inclusion of CEO Pascal Soriat in a high-profile meeting with President Xi Jinping, signaling political rehabilitation.
  • "Politically significant meeting... photographed alongside the leader." – Eleanor Olcott [08:24]

• Strategic Moves:

  • Pledge of $2.5 billion investment for a biotech research center in Beijing.
  • Deep alignment of interests with Chinese government priorities (domestic R&D investment).

Employee Impact and Outlook

• Long-Term Prospects:
  • AstraZeneca’s innovative pipeline remains solid.
  • The emotional aftermath for staff remains unresolved.
  • Quote: “I would just add here that this has been a very difficult time for AstraZeneca employees in China. We spoke to one employee who talked about how difficult the environment had been. I mean, Leon's presence still looms large over the company...” – Eleanor Olcott [10:45]

Timestamps:

• [07:25] Eleanor Olcott outlines the scandal’s context
• [08:24] Political rehabilitation highlighted
• [09:27] Investments and government alignment
• [10:45] Reflections on employee morale and future challenges

---

Notable Quotes

• “The transformation has been enormous. Difficult, really, to find a comparison. It's transformed the country from being the second poorest in the Western Hemisphere, behind Haiti, into being the world's fastest growing economy.”
  — Joe Daniels on Guyana [02:23]

• “It's so momentous because the sheer size of revenues that are going to come in over the next five years are so enormous over the next presidential term. The amount of money coming in is potentially transformative.”
  — Joe Daniels [05:14]

• “Really, we've got a situation where AstraZeneca's and the Chinese government's interests are aligned here.”
  — Eleanor Olcott [09:27]

---

Useful Segments (Timestamps)

• [00:45] China-India partnership statement and context
• [02:08] Introduction to Guyana’s oil boom and election
• [03:03] Election campaign details and party positions
• [05:14] “Mother of all elections” and resource curse warning
• [06:13] UK-Norway warship deal and NATO context
• [07:25] AstraZeneca’s scandal in China
• [08:24] Signs and symbols of corporate recovery
• [09:27] Strategic investments in China
• [10:45] Employee experience and future outlook for AstraZeneca China

---

Episode Tone

The episode maintains the professional, concise, and analytical tone characteristic of Financial Times journalism, focusing on clear context, big-picture implications, and crisp delivery of complex news.

---

For further reading and in-depth coverage, check the show notes linked in the episode.

Transcript

[A]

Markets move fast. Get the insights you need in 10 minutes with Barclays Brief, a podcast from Barclays Investment Bank. Each week, our experts analyze market themes, helping you anticipate what's next. Listen to Barclays Brief wherever you get your podcasts.

[B]

Good morning from the Financial Times. Today is Monday, September 1, and this is your FT news briefing. Beijing and New Delhi are continuing to build closer ties and Guyana heads to the polls for a high stakes election. Plus, drug maker AstraZeneca is bouncing back after a scandal in China.

[C]

Really, we've got a situation where AstraZeneca's and the Chinese government's interests are aligned here.

[B]

I'm Persis Love and here's the news you need to start your day. China and India are, quote, partners, not rivals. So said Chinese President Xi Jinping after meeting with his Indian counterpart, Narendra Modi on Sunday. The pair spoke at a regional security summit in the Chinese city of Xianxin, and the conversation was closely watched. For one thing, Xi and Modi lead the world's two most populous countries, each with large nuclear stockpiles. And then in recent years, tensions between the two have been high, with some clashes along their shared Himalayan border. But the trade war between each country and the United States has opened up opportunities for cooperation. As things currently stand, India faces a world leading 50% rate on exports to the US. Guyana heads to the polls. Today is shaping up to be a momentous election for the small South American nation. Guyana's the world's newest petro state, and an influx of oil riches is changing what politicians can promise their voters. Here to tell me why this election matters is the FT's Joe Daniels. Hi, Joe.

[D]

Hello.

[B]

So, Joe, before we jump into the politics, help us just to understand a little bit more about Guyana and its relationship to oil. It's been about 10 years now since ExxonMobil first discovered massive reserves of oil there. How has that changed the country?

[D]

Well, the transformation has been enormous. Difficult, really, to find a comparison. It's transformed the country from being the second poorest in the Western Hemisphere, behind Haiti, into being the world's fastest growing economy. It's a population of 830,000 people, landmass a little bigger than England. The discoveries so far are 11 billion barrels of oil equivalent. And with such a small population, it's oil per capita ratio that's equivalent to the Middle East.

[B]

Okay, so how are oil politics playing out in this election campaign?

[D]

Well, it's affecting the candidates primarily on how they're going to spend the windfall of money that's going to come in over the next five years, something analysts estimate at around $41 billion. On the one hand, we have the current president of Guyana up for a second term, Irfan Ali of the People's Progressive Party. And he really wants to keep the deal with Exxon. Its partners the same. They want to keep their project going. And that's a project that is essentially driven by heavy spending on infrastructure, on building bridges, roads, schools, et cetera, and doing kind of public private partnerships to get this stuff built. In the opposition you have Aubrey Norton of the Partnership for National Unity Party or apnu. And what they're about is a much more kind of welfare state kind of model about getting money more directly into the pockets of the Guyanese, many of which are unhappy that they're not yet feeling the benefits of this oil boom.

[B]

Okay, two part is two very different visions then. Any chance for a spoiler?

[D]

There certainly is. Shaking up this duopoly is this new party called the WIN Party, which is led by a chap called Azreddin Mohammed. He's the son of one of Guyana's wealthiest men who made his millions in gold trading. And what Ezrad Mohammed is pledging is a sort of mix of economic populism. He also wants to renegotiate terms with Exxon. He's painting himself as a national unifier. He's drawing crowds. And while analysts aren't convinced he could win an outright majority with his party and become the president, there is a concern that his party could win a few seats and really disrupt things for whoever does win.

[B]

And Jo, you spoke to someone who described this election as the mother of all elections. Why is this one so momentous?

[D]

It's so momentous because the sheer size of revenues that are going to come in over the next five years are so enormous over the next presidential term. The amount of money coming in is potentially transformative. There's of course also the huge risk of so called resource curse of becoming so distorted by all these oil revenues that we start to see rampant corruption and a weakened economy in everything but oil and susceptible to global oil shocks. So the question as well of what's at stake is who manages this initial kind of development process for a country that I Repeat was the second poorest in the Americas just six years ago.

[B]

Joe Daniels is the FT's Andean correspondent. Thanks Joe.

[D]

Thank you.

[B]

The UK has won a contract to supply Norway with at least five warships. The 10 billion pound deal is the largest ever for Britain's warship sector and the frigates will be built by BAE Systems in Glasgow. The new vessels are being built to counter Russian submarine activity in the Arctic and North Atlantic. Those two regions have become important theaters for NATO since Russia's full scale invasion of Ukraine in 2022. Just this past week, British, Norwegian and US forces have been actively monitoring a Russian submarine in the North Atlantic. That's according to the UK Ministry of Defence. BAE Systems is also helping to design and build warships for other UK allies like Canada and Australia. Less than A year ago, AstraZeneca's China division was embroiled in a scandal. There was a probe into alleged illegal drug sales and the then regional head was arrested. But today, the pharmaceuticals group's China business seems to have bounced back. Here to tell us how they managed the comeback is Eleanor Olcott. She covers China for the ft. Hi, Elena.

[C]

Hi, Persis.

[B]

Okay, so give me the backstory here. What's been going on with AstraZeneca in China?

[C]

So AstraZeneca is the biggest global pharmaceutical company in China by sales. China is a very, very important market for the British drug maker. It's been very successful in China through various localization efforts and particularly kind of by investing a lot of authority in their very powerful former China boss, Leon Wang. And at the end of last year, Leon was arrested in Conn. This kind of probe into the alleged illegal importation and sale of a cancer drug in China. So this was a big, big shock for AstraZeneca. It was also a big shock for investors. Its share price fell by about 10% the day that news came out.

[B]

Okay, and then what are the signs that the company has bounced back in China?

[C]

Well, the first is pure numbers, right? So in the first half of the year, AstraZeneca sales in China were up 4%. That's not dramatic, but it's still significant given the backstory here. And the second indication is this kind of very politically significant meeting between AstraZeneca CEO Pascal Soriat. He was included in a group of CEOs who met with President Xi Jinping in March and photographed alongside the leader. Now, this group of individuals, the kind of list of attendees to this meeting is heavily, heavily scrutinized. And it's kind of in the grand theatre of CCP politics. It's very significant that AstraZeneca, especially having gone through this recent scandal in China, was included in this kind of very Elite list of CEOs chosen for this meeting with Xi Jinping.

[B]

How has it managed this recovery? What has the strategy been to get back in Beijing's good Books.

[C]

There's been a number of things that AstraZeneca has done in the immediate aftermath of the scandal, but really the most important thing that they've done is pledge $2.5 billion for a new research center in Beijing. Now, China is very, very keen for foreign companies to be investing in China. And so the fact that you've got such a huge investment in a strategically significant industry like bio tech, really, we've got a situation where AstraZeneca and the Chinese government's interests are aligned here. So I think really the politics around that investment have helped AstraZeneca to kind of ease their position and do a bit of good government relations in China.

[B]

Okay, so AstraZeneca is doing well right now. Do you expect their China business to keep moving in the right direction?

[C]

So AstraZeneca's got a pretty good pipeline of drugs. They also have been purchasing some innovative assets in China to kind of beef up their pipeline of new drugs. So it looks like they're in a good position. I would just add here that this has been a very difficult time for AstraZeneca employees in China. We spoke to one employee who talked about how difficult the environment had been. I mean, Leon's presence still looms large over the company. So I think. I think that part of the puzzle has still not yet been answered by the new leadership team. But that shouldn't be a kind of existential issue.

[B]

That's the FT's Elena Olcott in Beijing. Thanks, Elena.

[C]

Thank you.

[B]

You can read more on all these stories for free when you click on the links in our show notes. This has been your daily FT news briefing. Check back tomorrow for the latest business news.

[C]

Thinking long term about your investment career? Hear stories, advice and lessons from seasoned.

[D]

Leaders at Capital Group on the Capital Ideas podcast. Subscribe and start listening today. Published by Capital Client Group Inc.

[A]

Flowers die in three days. Matching underwear from Meundies. That's a gift that lasts. Meundies creates matching prints for couples and friends. Same adorable designs in different cuts for each of you. All made from their signature ultramodal fabric that feels impossibly soft. With 30 million pairs sold and 90,000 five star reviews, Meundi's matching prints are the perfect gift. Valentine's Day is February 14th, so don't wait. Get exclusive deals up to 50% off at Meundies.com acast code acast that's Meundies.com acast Code acast.